Global Autoimmune Disease Diagnosis Market to Reach $8.81 Billion by 2029, Growing at 9% CAGR

What combination of drivers is leading to accelerated growth in the autoimmune disease diagnosis market?
The surge in autoimmune diseases incidences has played a significant role in propelling the autoimmune disease diagnosis market. Take for example in February 2023, the Australia-based national non-profit body, multiple sclerosis Australia which is committed to research and advocacy for those impacted by multiple sclerosis, reported that 33,335 Australians were confirmed with Multiple Sclerosis in 2021. This was a significant increase of 30% (7,728) compared to the preceding four years data (25,607). Therefore, it is clear that the elevation in the incidence of autoimmune diseases worldwide is acting as a growth stimulus for the autoimmune disease diagnosis market.

Get Your Autoimmune Disease Diagnosis Market Report Here:
https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

What is the projected compound annual growth rate (CAGR) of the autoimmune disease diagnosis market from 2025 to 2034, and what factors influence it?
In recent times, there has been a significant growth in the autoimmune disease diagnosis market. Its size is projected to rise from $5.84 billion in 2024 to $6.25 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%. Factors contributing to this growth during the historic period include an increasing rate of autoimmune diseases, expansion of emerging markets, a surge in healthcare spending, and a higher occurrence in women.

The market size for diagnosing autoimmune diseases is anticipated to experience substantial expansion in the coming years. It is projected to amplify to $8.81 billion by 2029, with a compound annual growth rate (CAGR) of 9.0%. The market expansion during the predicted period can be ascribed to the rise in funding for autoimmune (ai) diagnostics, swift economic growth, a heightened understanding of autoimmune conditions, and discovery of biomarkers. Predominant tendencies during this period include collaborations with other industry players, investments in artificial intelligence firms, forging partnership with government entities and development of quick at-home testing kits.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3231&type=smp

How are the latest trends influencing the growth of the autoimmune disease diagnosis market?
Biosensors and nano biosensors are revolutionary instruments in the autoimmune disease diagnosis market for speedy detection of antibodies. These tools are preferred due to their affordability, high sensitivity, straightforward utilization, ability to perform multiple diagnoses, and quick results. Not only do they assess the amount of antibodies in human blood serum with unbeatable sensitivity, but they also gauge the function of these antibodies, thanks to the assay utilizing portable, label-free optical biosensors underpinned by spectral correlation interferometry. This point-of-care tech offers a more comprehensive, insightful, prompt, and accurate diagnosis of autoimmune diseases compared to traditional methods.

What are the major segments of the autoimmune disease diagnosis market and their role in driving growth?
The autoimmune disease diagnosis market covered in this report is segmented -

1) By Product: Consumables And Assay Kits, Instruments
2) By End User: Clinical Laboratories, Hospitals, Others
3) By Test Type: Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests

Subsegments:
1) By Consumables And Assay Kits: ELISA Kits, Reagents And Test Kits, Sample Collection And Preservation Devices, Control And Calibration Materials
2) By Instruments: Immunoassay Analyzers, Flow Cytometers, Luminometers, Microscopes, Other Diagnostic Devices

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3231

Which regions are key players in the growth of the autoimmune disease diagnosis market?
North America was the largest region in the autoimmune disease diagnosis market in 2024. Western Europe was the second largest region in the autoimmune disease diagnosis market share. The regions covered in the autoimmune disease diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the key firms paving the way for growth in the autoimmune disease diagnosis market?
Major companies operating in the autoimmune disease diagnosis market include Siemens Healthineers AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Danaher Corporation, AESKU Diagnostics GmbH & Co. KG, Trinity Biotech plc., bioMérieux SA, SQI Diagnostics, SCHILLER Healthcare India Pvt. Ltd, Covidien Healthcare India Private Limited, Philips Healthcare India, Fisher & Paykel Healthcare India Private Limited, Smith's Medical India Pvt Ltd, Agappe Diagnostics Ltd, Accord Medical Products Private Limited, Lepu Medical Technology Company (Beijing) Co., Ltd, Yuwell - Jiangsu Yuyue Medical Equipment & Supply Co., Ltd, Shanghai Runda Medical Technology Co., Ltd, GE Healthcare China Co., Ltd, Roche Holding AG, Koninklijke Philips, Theradiag, Sanofi, Themis Bioscience, Becton Dickinson and Company

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=3231&type=smp

What Is Covered In The Autoimmune Disease Diagnosis Global Market Report?

•Market Size Forecast: Examine the autoimmune disease diagnosis market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the autoimmune disease diagnosis market for a structured understanding.
•Key Players Overview: Analyze major players in the autoimmune disease diagnosis market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the autoimmune disease diagnosis market.
•Segment Contributions: Evaluate how different segments drive overall growth in the autoimmune disease diagnosis market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the autoimmune disease diagnosis market.
•Industry Challenges: Identify potential risks and obstacles affecting the autoimmune disease diagnosis market.
•Competitive Landscape: Review strategic developments in the autoimmune disease diagnosis market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.